Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

ION* Sinus Support Nasal Spray, 1 fl oz/30 ml bottles, Manufactured by: ION* Intelligence of Nature Charlottesville, VA

by Biomic Sciences, LLC dba ION Intelligence of Nature

Reason: Microbial contamination of Non-Sterile Products
Recall initiated: September 29, 2023
Reported by FDA: November 1, 2023
Distribution: Nationwide in the United States and to Canada, New Zealand, Australia, Indonesia, Malaysia, Great Britain, and the Netherlands

View recall →

Drug Recall Terminated Historical recordClass I

IONSinus Spray, 1 fl oz/ 30 mL, Manufactured by: ION Biome Charlottesville, VA

by Biomic Sciences, LLC dba ION Intelligence of Nature

Reason: Microbial contamination of Non-Sterile Products
Recall initiated: September 29, 2023
Reported by FDA: November 1, 2023
Distribution: Nationwide in the United States and to Canada, New Zealand, Australia, Indonesia, Malaysia, Great Britain, and the Netherlands

View recall →

Drug Recall Ongoing Historical recordClass III

Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25

by West-Ward Columbus Inc

Reason: Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Recall initiated: September 22, 2023
Reported by FDA: November 1, 2023
Distribution: MS, OH

View recall →

Drug Recall Terminated Historical recordClass II

Foscarnet Sodium 2.4mg/0.1 mL solution for injection, 0.2 mL single-dose Staclear Luer Slip Syringe, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Tropi-Phen (tropicamide 1%, phenylephrine 2.5%) ophthalmic solution, 5mL multi-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine HCl 4% ophthalmic solution, 3 mL single-use dropper, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

TPC Drops (tropicamide 1%- phenylephrine 2.5%- cyclopentolate HCl 1% ophthalmic solution, 5 mL droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose Vial, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Cefuroxime 4mg /0.4 mL (10 mg/mL), 1mL syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Moxifloxacin in Balanced Salt Solution, Solution for Intraocular Injection, 600 mcg/0.4mL (150 mcg/0.1mL) Syringe, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Tropi-Phen (Tropicamide 1% phenylephrine HCl 2.5%) ophthalmic solution, 15 mL multi-use Droppers, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Gluconate 2.5% solution for inhalation, 5mL pre-filled syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Calcium Gluconate Ophthalmic Irrigation Solution 1%, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Endophth Kit (Vancomycin 1mg/0.1 mL - Ceftazidime 2.25mg/0.1 mL), Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Vancomycin 1 MG/0.1 ML Solution for Intraocular Injection, 0.8 ML Single Dose Vial, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

by Pine Pharmaceuticals, LLC

Reason: Lack of Assurance of Sterility
Recall initiated: October 2, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass I

Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10702-013-01.

by KVK-Tech, Inc.

Reason: Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.
Recall initiated: September 20, 2023
Reported by FDA: October 25, 2023
Distribution: Nationwide in the USA and PR

View recall →

Data last updated: September 10, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.